Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-POUR
NCT04491526Phase 4Terminated
- Start
- Nov 2020
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in postoperative urinary retention (POUR) comparing Tamsulosin Arm with Placebo Arm (2 arms). Primary endpoint: Post operative urinary retention at 3 days. Started Nov 2020; status: terminated.
02
Drugs
tamsulosin
03
Conditions
postoperative urinary retention (POUR)
Beyond the preview
Go deeper on NCT04491526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04491526.